ATXI
Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI
Delisted
ATXI was delisted on the 18th of March, 2025.
8 hedge funds and large institutions have $771K invested in Avenue Therapeutics, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
8
Holders Change
+6
Holders Change %
+300%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$89K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Millennium Management
New York
| $258K | 46,702 | +46,702 | New |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $136K | 24,540 | +24,540 | New |
|
3
BlackRock
New York
| $91K | 16,385 | +16,385 | New |
|
|
4
Goldman Sachs
New York
| $89K | 16,018 | -11,482 | -42% |
|
|
BRWA
5
B. Riley Wealth Advisors
Boca Raton,
Florida
| $83K | 15,000 | +15,000 | New |
|
|
SIM
6
Spark Investment Management
New York
| $69K | 12,493 | +12,493 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $41K | 7,325 | +7,325 | New |
|
8
Morgan Stanley
New York
| $4K | 796 | +796 | New |
|
|
9
UBS Group
Zurich,
Switzerland
| – | – | -1,090 | Closed |
|